COVINA, CA -- (MARKET WIRE) -- March 22, 2007 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that research protocols are being prepared to treat women who have undergone mastectomies and patients that been disfigured by other surgeries or injuries requiring bone and facial implants. Tissue engineered from the Company's patented adult stem cell process offers clinical advantages in that the implants retain their shape and structure and also eliminate a separate surgery to extract healthy tissue. The Company intends to commercialize its proprietary technology through packaged products and licensing agreements, once human clinical trials are completed.
